BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11179198)

  • 1. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis.
    Andreka P; Zang J; Dougherty C; Slepak TI; Webster KA; Bishopric NH
    Circ Res; 2001 Feb; 88(3):305-12. PubMed ID: 11179198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis.
    Srivastava RK; Sollott SJ; Khan L; Hansford R; Lakatta EG; Longo DL
    Mol Cell Biol; 1999 Aug; 19(8):5659-74. PubMed ID: 10409755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway.
    Maroney AC; Glicksman MA; Basma AN; Walton KM; Knight E; Murphy CA; Bartlett BA; Finn JP; Angeles T; Matsuda Y; Neff NT; Dionne CA
    J Neurosci; 1998 Jan; 18(1):104-11. PubMed ID: 9412490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling and function of caspase and c-jun N-terminal kinase in cisplatin-induced apoptosis.
    Koo MS; Kwo YG; Park JH; Choi WJ; Billiar TR; Kim YM
    Mol Cells; 2002 Apr; 13(2):194-201. PubMed ID: 12018840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis.
    Widmann C; Gerwins P; Johnson NL; Jarpe MB; Johnson GL
    Mol Cell Biol; 1998 Apr; 18(4):2416-29. PubMed ID: 9528810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPK signaling is involved in camptothecin-induced cell death.
    Lee S; Lee HS; Baek M; Lee DY; Bang YJ; Cho HN; Lee YS; Ha JH; Kim HY; Jeoung DI
    Mol Cells; 2002 Dec; 14(3):348-54. PubMed ID: 12521296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes.
    Qiao L; Han SI; Fang Y; Park JS; Gupta S; Gilfor D; Amorino G; Valerie K; Sealy L; Engelhardt JF; Grant S; Hylemon PB; Dent P
    Mol Cell Biol; 2003 May; 23(9):3052-66. PubMed ID: 12697808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis.
    Isakovic A; Harhaji L; Stevanovic D; Markovic Z; Sumarac-Dumanovic M; Starcevic V; Micic D; Trajkovic V
    Cell Mol Life Sci; 2007 May; 64(10):1290-302. PubMed ID: 17447005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide mediates the indole acetic acid induction activation of a mitogen-activated protein kinase cascade involved in adventitious root development.
    Pagnussat GC; Lanteri ML; Lombardo MC; Lamattina L
    Plant Physiol; 2004 May; 135(1):279-86. PubMed ID: 15122018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3.
    Subramaniam S; Zirrgiebel U; von Bohlen Und Halbach O; Strelau J; Laliberté C; Kaplan DR; Unsicker K
    J Cell Biol; 2004 May; 165(3):357-69. PubMed ID: 15123736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of arrestin-3 by caspases attenuates cell death by precluding arrestin-dependent JNK activation.
    Kook S; Vishnivetskiy SA; Gurevich VV; Gurevich EV
    Cell Signal; 2019 Feb; 54():161-169. PubMed ID: 30529266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The imidazoline RX871024 induces death of proliferating insulin-secreting cells by activation of c-jun N-terminal kinase.
    Zaitseva II; Størling J; Mandrup-Poulsen T; Berggren PO; Zaitsev SV
    Cell Mol Life Sci; 2008 Apr; 65(7-8):1248-55. PubMed ID: 18278435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sevoflurane Pre-conditioning Ameliorates Diabetic Myocardial Ischemia/Reperfusion Injury Via Differential Regulation of p38 and ERK.
    Xie D; Zhao J; Guo R; Jiao L; Zhang Y; Lau WB; Lopez B; Christopher T; Gao E; Cao J; Ma X; Wang Y
    Sci Rep; 2020 Jan; 10(1):23. PubMed ID: 31913350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors.
    Vaidya T; Kamta J; Chaar M; Ande A; Ait-Oudhia S
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):401-418. PubMed ID: 29446053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling Pathways in Cardiac Myocyte Apoptosis.
    Xia P; Liu Y; Cheng Z
    Biomed Res Int; 2016; 2016():9583268. PubMed ID: 28101515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and promotion of cardiac myocyte apoptosis.
    Andréka P; Tran T; Webster KA; Bishopric NH
    Mol Cell Biochem; 2004 Aug; 263(1):35-53. PubMed ID: 27520664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell death and survival in heart regeneration and repair.
    Abdelwahid E; Kalvelyte A; Stulpinas A; de Carvalho KA; Guarita-Souza LC; Foldes G
    Apoptosis; 2016 Mar; 21(3):252-68. PubMed ID: 26687129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.
    Javadov S; Jang S; Agostini B
    Pharmacol Ther; 2014 Nov; 144(2):202-25. PubMed ID: 24924700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection acquired through exercise: the role of ischemic preconditioning.
    Marongiu E; Crisafulli A
    Curr Cardiol Rev; 2014 Nov; 10(4):336-48. PubMed ID: 24720421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y2 receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivo.
    Hochhauser E; Cohen R; Waldman M; Maksin A; Isak A; Aravot D; Jayasekara PS; Müller CE; Jacobson KA; Shainberg A
    Purinergic Signal; 2013 Dec; 9(4):633-42. PubMed ID: 23828651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.